The two faces of regulatory t cells in cancer

OncoImmunology

Volumn 2, Issue 5, 2013, Pages

  Blatner, Nichole R ^a   Gounari, Fotini ^b   Khazaie, Khashayarsha ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Colon cancer; Inflammation; Polyposis; ROR t; Treg

Indexed keywords

RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CELL DENSITY; CELL EXPANSION; CELL FUNCTION; CELL TRANSPORT; COLON CANCER; DISEASE ASSOCIATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TARGET CELL DESTRUCTION; TH17 CELL; TUMOR ASSOCIATED LEUKOCYTE;

EID: 84886945471     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23852     Document Type: Article

References (10)

1. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960-4; PMID:17008531; http://dx.doi. org/10.1126/science.1129139
2. Khazaie K, Bonertz A, Beckhove P. Current developments with peptide-based human tumor vaccines. Curr Opin Oncol 2009; 21:524-30; PMID:19770763; http://dx.doi.org/10.1097/CCO.0b013e328331a78e
3. Wilke CM, Kryczek I, Wei S, Zhao E, Wu K, Wang G, et al. Th17 cells in cancer: help or hindrance? Carcinogenesis 2011; 32:643-9; PMID:21304053; http://dx.doi.org/10.1093/carcin/bgr019
4. Khazaie K, Blatner NR, Khan MW, Gounari F, Gounaris E, Dennis K, et al. The significant role of mast cells in cancer. Cancer Metastasis Rev 2011; 30:45-60; PMID:21287360; http://dx.doi.org/10.1007/s10555-011-9286-z
5. Gounaris E, Blatner NR, Dennis K, Magnusson F, Gurish MF, Strom TB, et al. T-regulatory cells shift from a protective anti-inflammatory to a cancerpromoting proinflammatory phenotype in polyposis. Cancer Res 2009; 69:5490-7; PMID:19570783; http://dx.doi.org/10.1158/0008-5472.CAN-09-0304
6. Blatner NR, Bonertz A, Beckhove P, Cheon EC, Krantz SB, Strouch M, et al. In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci U S A 2010; 107:6430-5; PMID:20308560; http://dx.doi.org/10.1073/pnas.0913683107
7. Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, et al. Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 2012; 4:ra159; PMID:23241743; http://dx.doi.org/10.1126/scitranslmed. 3004566
8. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, et al. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263-71; PMID:21303976; http://dx.doi.org/10.1158/0008-5472.CAN-10-2907
9. Bos PD, Rudensky AY. Treg cells in cancer: a case of multiple personality disorder. Sci Transl Med 2012; 4:64fs44; PMID:23241741; http://dx.doi. org/10.1126/scitranslmed.3005283
10. Erdman SE, Poutahidis T. Cancer inflammation and regulatory T cells. Int J Cancer 2010; 127:768-79; PMID:20518013